Literature DB >> 35781349

The obesity paradox for survivors of critically ill patients.

Dawei Zhou1, Chao Wang1, Qing Lin1, Tong Li2.   

Abstract

The obesity paradox has been observed in short-term outcomes from critical illness. However, little is known regarding the impact of obesity on long-term outcomes for survivors of critically ill patients. We aimed to evaluate the influence of obesity on long-term mortality outcomes after discharge alive from ICU. The adult patients who were discharged alive from the last ICU admission were extracted. After exclusion, a total of 7619 adult patients discharged alive from ICU were included, with 4-year mortality of 32%. The median body mass index (BMI) was 27.2 (IQR 24-31.4) kg/m2, and 2490 (31.5%) patients were classified as obese or morbidly obese. The morbidly obese patients had the highest ICU and hospital length of stay. However, higher BMI was associated with lower hazard ratio for 4-year mortality. The results showed the obesity paradox may be also suitable for survivors of critically ill patients.
© 2022. The Author(s).

Entities:  

Keywords:  Critical care; Mortality; Obesity paradox; Survivors

Mesh:

Year:  2022        PMID: 35781349      PMCID: PMC9251913          DOI: 10.1186/s13054-022-04074-1

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   19.334


Background

Survivors of critically ill patients are at risk of experiencing significant physical, cognitive, and mental health issues, which were associated with an increased mortality following discharge from intensive care unit (ICU) [1-4]. However, factors associated with mortality for survivors of critical illness are not well understood, which may be important when counseling patients and families. The obesity paradox, which is the phenomenon that obesity increases the risk of obesity-related diseases but paradoxically is associated with survival benefits, has been observed in short-term outcomes from critical illness [5-7]. Nonetheless, little is known regarding the impact of obesity on long-term outcomes after discharge from intensive care unit (ICU). We, therefore, aimed to evaluate the influence of obesity on 4-year mortality outcome for survivors of critically illness.

Methods

Data were extracted from the online database Medical Information Mart for Intensive Care (MIMIC III) [8]. We included adult patients who were discharged alive from the last ICU admission. The exclusion criteria were: (1) No weight and height data available, (2) body mass index (BMI) < 10 kg/m2 or > 70 kg/m2, (3) No follow-up survival data available. We abstracted the height and weight data from the Electronic Medical Records (EMR) when admitted to ICU. The BMI was calculated using the equation: BMI (kg/m2) = weight (kg)/height2 (m2). BMI was examined as both a categorical and continuous variable. According to the international standards [9], obesity was assessed as a categorical variable according to BMI (BMI less than 10.0 or greater than 70.0 kg/m2 was excluded): underweight, BMI < 18.5 k kg/m2; normal weight, 18.5 ≤ BMI < 25 kg/m2; overweight, 25 ≤ BMI < 30 kg/m2; obese, 30 ≤ BMI < 40 kg/m2; morbidly obese, BMI ≥ 40 kg/m2. The primary endpoint was 4-year mortality which was extracted from the social security database and was considered as a time-to-event variable. Baseline and clinical characteristics were compared among different BMI categories. Multiple imputation was used to deal with the missing data with the mice package [10]. We used Cox proportional hazards regression model to produce adjusted hazard ratios (HRs) for the association between BMI and 4-year mortality with normal weight as reference. To better understand the effect of BMI on 4-year mortality as a continuous covariate in multivariable Cox model, the splines-based HR curve was expressed with smoothHR package [11]. The PostgreSQL (version 10, www.postgresql.org) was used for data extraction, and R software (version 3.5.1, www.r-project.org) was used to conduct all the statistical analysis.

Results

After exclusion, 7619 adult patients discharged alive from ICU were included, with 4-year mortality of 32% (Table 1). The median BMI was 27.2 (IQR 24–31.4) kg/m2. 2490 (31.5%) patients were classified as obese or morbidly obese. As expected, higher BMI patients had a higher percentage of comorbidities of hypertension and diabetes mellitus. The morbidly obese patients had the highest ICU and hospital length of stay. The underweight patients had the highest 4-year mortality (62%). The higher BMI was associated with lower HR for 4-year mortality.
Table 1

Baseline and clinical characteristics of the study patients by BMI categories

VariablesTotalUnderweight (BMI < 18.5 kg/m2)Normal weight (18.5 kg/m2 ≤ BMI < 25 kg/m2)Overweight (25 kg/m2 ≤ BMI < 30 kg/m2)Obese (30 kg/m2 ≤ BMI < 40 kg/m2)Morbidly obese (BMI ≥ 40 kg/m2)
Number of patients7916 (100)206 (2.6)2368 (29.9)2852 (36.0)2065 (26.1)425 (5.4)
Age, years65 (54, 76)69 (55, 78)69 (54, 79)66 (55, 76)63 (54, 73)58 (50, 66)
Sex: male5023 (63)80 (39)1371 (58)2014 (71)1349 (65)209 (49)
BMI, kg/m227.2 (24.0, 31.4)17.4 (16.4, 18.1)22.9 (21.5, 24.0)27.3 (26.2, 28.5)33.0 (31.4, 35.3)44.1 (41.7, 48.1)
Ethnicity
 White5397 (68)129 (63)1608 (68)1951 (68)1405 (68)304 (72)
 Others2519 (32)77 (37)760 (32)901 (32)660 (32)121 (28)
Marital status
 Married4373 (55)80 (39)1245 (53)1660 (58)1171 (57)217 (51)
 Single1511 (19)59 (29)466 (20)513 (18)364 (18)109 (26)
 Widowed1009 (13)34 (17)366 (15)320 (11)250 (12)39 (9)
 Divorced469 (6)13 (6)111 (5)169 (6)142 (7)34 (8)
 Others554 (7)20 (10)180 (8)190 (7)138 (7)26 (6)
Insurance type
 Medicare4007 (51)126 (61)1315 (56)1418 (50)983 (48)165 (39)
 Private3171 (40)64 (31)796 (34)1183 (41)916 (44)212 (50)
 Medicaid452 (6)13 (6)150 (6)157 (6)97 (5)35 (8)
 Government197 (2)3 (1)66 (3)64 (2)54 (3)10 (2)
 Self-pay89 (1)0 (0)41 (2)30 (1)15 (1)3 (1)
Comorbidities
 Hypertension4457 (56)94 (46)1169 (49)1622 (57)1325 (64)247 (58)
 Diabetes mellitus2077 (26)33 (16)445 (19)663 (23)754 (37)182 (43)
 Tumor525 (7)22 (11)182 (8)175 (6)119 (6)27 (6)
 Respiratory disease1212 (15)52 (25)375 (16)357 (13)321 (16)107 (25)
 CHF2146 (27)61 (30)662 (28)731 (26)548 (27)144 (34)
 Liver disease273 (3)6 (3)97 (4)96 (3)65 (3)9 (2)
 Renal failure643 (8)25 (12)202 (9)219 (8)160 (8)37 (9)
ICU types
 CCU1341 (17)24 (12)397 (17)511 (18)338 (16)71 (17)
 MICU3803 (48)64 (31)1071 (45)1438 (50)1062 (51)168 (40)
 CSRU1191 (15)67 (33)379 (16)368 (13)289 (14)88 (21)
 SICU906 (11)31 (15)272 (11)312 (11)235 (11)56 (13)
 TSICU675 (9)20 (10)249 (11)223 (8)141 (7)42 (10)
ICU scoring systems
 SOFA score4 (2, 6)4 (2, 5)4 (2, 6)4 (2, 6)4 (2, 6)4 (2, 6)
 SAPS II31 (24, 40)36 (28, 43)33 (25, 41)31 (24, 39)30 (23, 39)30 (22, 40)
ICU LOS, days3 (2, 5)3 (2, 5)3 (2, 5)3 (2, 5)3 (2, 5)4 (2, 7)
Hospital LOS, days8 (6, 13)9 (6, 16)8 (6, 13)8 (6, 12)8 (6, 13)9 (6, 16)
Hospital discharge location
 Home1980 (25)46 (22)539 (23)768 (27)535 (26)92 (22)
 Home health care3003 (38)52 (25)852 (36)1144 (40)806 (39)149 (35)
 Rehabilitation center1364 (17)44 (21)441 (19)420 (15)355 (17)104 (24)
 Hospice60 (1)3 (1)21 (1)24 (1)6 (0)6 (1)
 Skilled nurse facility1077 (14)48 (23)383 (16)348 (12)251 (12)47 (11)
 Others432 (5)13 (6)132 (6)148 (5)112 (5)27 (6)
 Four-year mortality2571 (32)127 (62)920 (39)821 (29)582 (28)121 (28)

Data are median (interquartile range) or No/Total (%)

BMI body mass index, CHF chronic heart failure, CKD chronic kidney disease, ICU intensive care unit, CCU Coronary Care Unit, CSRU Cardiac Surgery Recovery Unit, TSICU Trauma Surgical ICU, MICU Medical ICU, SICU Surgical ICU, SOFA sequential organ failure assessment, SAPS Simplified acute physiology score, LOS length of stay

Baseline and clinical characteristics of the study patients by BMI categories Data are median (interquartile range) or No/Total (%) BMI body mass index, CHF chronic heart failure, CKD chronic kidney disease, ICU intensive care unit, CCU Coronary Care Unit, CSRU Cardiac Surgery Recovery Unit, TSICU Trauma Surgical ICU, MICU Medical ICU, SICU Surgical ICU, SOFA sequential organ failure assessment, SAPS Simplified acute physiology score, LOS length of stay Underweight and normal-weight patients had a lower probability of 4-year survival (Fig. 1B). When considering normal-weight patients as the reference, underweight patients had higher adjusted HR for mortality, while overweight and obese patients had lower adjusted HRs (Fig. 1C). When using BMI as a continuous variable, the pointwise estimation of the adjusted HR curve showed a nonlinear relationship between BMI and long-term mortality outcome, with a BMI of 28.9 kg/m2 the lowest HR (Fig. 1D).
Fig. 1

A Histogram and density distribution of body mass index (BMI); B Kaplan–Meier survival curves by BMI category (log-rank p < 0.001); C Adjusted hazards ratio (HR) for 4-year mortality according to BMI categories, with normal weight as reference. The HRs and 95% confidence intervals (error bars) for each categories were calculated using COX proportional hazard model after adjusting for age, sex, ethnicity, marital status, insurance type, comorbidities (hypertension, diabetes mellitus, tumor, respiratory disease, chronic heart failure, liver disease, and renal failure), ICU type, disease severity score of simplified acute physiology score (SAPS) II, and hospital discharge locations; D Smoothed HR (log transformation) curve with pointwise nonparametric estimation of association between BMI and 4-year mortality after adjusting for confounders (same with the confounders in C)

A Histogram and density distribution of body mass index (BMI); B Kaplan–Meier survival curves by BMI category (log-rank p < 0.001); C Adjusted hazards ratio (HR) for 4-year mortality according to BMI categories, with normal weight as reference. The HRs and 95% confidence intervals (error bars) for each categories were calculated using COX proportional hazard model after adjusting for age, sex, ethnicity, marital status, insurance type, comorbidities (hypertension, diabetes mellitus, tumor, respiratory disease, chronic heart failure, liver disease, and renal failure), ICU type, disease severity score of simplified acute physiology score (SAPS) II, and hospital discharge locations; D Smoothed HR (log transformation) curve with pointwise nonparametric estimation of association between BMI and 4-year mortality after adjusting for confounders (same with the confounders in C)

Discussion

In the present study, a significant proportion of patients discharging from ICU survive less than 4 years. Among survivors of critical illness, obesity was associated with lower 4-year mortality. The high mortality of survivors discharging from ICU was in line with previous studies [12, 13]. In the study of Brinkman et al. [12], the mortality risk at 3 years after hospital discharge was 27.5%; and the 5 years mortality was 26.9% in the study of Doherty et.al, which was higher than the general age-matched population [13]. In view of the prevalence of obesity continuing to rise among the ICU population [6], efforts to understand the impact of obesity long-term outcomes after critical illness should also be important [14]. The present study showed the mortality was high for ICU survivors and obesity was associated with reduced mortality; However, the underlying mechanisms were unknown. Several pathophysiologic mechanisms including higher energy reserves, anti-inflammatory immune profile, role of adipose tissue, and prevention of muscle wasting may contribute to explain this phenomenon [5]. Interestingly, according to the recent study of Drago et al. [15], the relationship of increasing BMI and lower risk of hypoglycemia might contribute to decreased mortality. The concept of obesity paradox has also been challenged. Martino et.al found that extreme obesity was not associated with a worse survival advantage after adjusted for confounders as well as had a longer duration of mechanical ventilation and ICU length of stay [16]. On the other hand, the BMI as a composite variable is intrinsically problematic, which is not an appropriate measure of fat and skeletal muscle mass and its distribution [17]. In the studies of Jaitovich et al. [18, 19], ICU admission pectoralis muscle area or erector spinae muscle mass was associated with survival outcomes, not was the subcutaneous adipose tissue mass. Similar studies were sparse for ICU survivors. As for survivors of critically ill patients, it is unclear whether it reflects a protective effect or limitations inherent to observational research for obesity paradox, which warrants further research. There were several limitations to our study. First, the retrospective design in nature was subjected to the inherent limitations even though adjusted for potential confounders. The other confounding factors including smoking status, alcohol consumption, income, education, physical activity, and dietary pattern may be involved, which were not extracted from the database. Second, the ICU admission height and weight data were extracted from the EMR with a higher missing rate. The method (estimation or measurement) for recording the height and weight was unknown. Third, the weight was a variable parameter relying on fluid balance, which could cause perturbation for calculation of BMI. As a result of these limitations, the present findings warrant a cautious interpretation, and more prospective cohort studies are needed to further elucidate this phenomenon.

Conclusions

In conclusion, our results suggest that the obesity paradox may be also suitable for survivors of critically ill patients.
  19 in total

1.  Increased risk of death and readmission after hospital discharge of critically ill patients in a developing country: a retrospective multicenter cohort study.

Authors:  Vanessa Chaves Barreto Ferreira de Lima; Ana Luiza Bierrenbach; Gizelton Pereira Alencar; Ana Lucia Andrade; Luciano Cesar Pontes Azevedo
Journal:  Intensive Care Med       Date:  2018-07-12       Impact factor: 17.440

Review 2.  Obesity in the critically ill: a narrative review.

Authors:  Miet Schetz; Audrey De Jong; Adam M Deane; Wilfried Druml; Pleun Hemelaar; Paolo Pelosi; Peter Pickkers; Annika Reintam-Blaser; Jason Roberts; Yasser Sakr; Samir Jaber
Journal:  Intensive Care Med       Date:  2019-03-19       Impact factor: 17.440

3.  Impact of body mass index on outcomes following critical care.

Authors:  Alain Tremblay; Venkata Bandi
Journal:  Chest       Date:  2003-04       Impact factor: 9.410

Review 4.  Is There an Obesity Paradox in Critical Illness? Epidemiologic and Metabolic Considerations.

Authors:  Irene Karampela; Evangelia Chrysanthopoulou; Gerasimos Socrates Christodoulatos; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2020-09

5.  Mortality after hospital discharge in ICU patients.

Authors:  Sylvia Brinkman; Evert de Jonge; Ameen Abu-Hanna; M Sesmu Arbous; Dylan W de Lange; Nicolette F de Keizer
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

6.  Multiple imputation with multivariate imputation by chained equation (MICE) package.

Authors:  Zhongheng Zhang
Journal:  Ann Transl Med       Date:  2016-01

7.  smoothHR: an R package for pointwise nonparametric estimation of hazard ratio curves of continuous predictors.

Authors:  Luís Meira-Machado; Carmen Cadarso-Suárez; Francisco Gude; Artur Araújo
Journal:  Comput Math Methods Med       Date:  2013-12-12       Impact factor: 2.238

Review 8.  Patient outcomes after critical illness: a systematic review of qualitative studies following hospital discharge.

Authors:  Mohamed D Hashem; Aparna Nallagangula; Swaroopa Nalamalapu; Krishidhar Nunna; Utkarsh Nausran; Karen A Robinson; Victor D Dinglas; Dale M Needham; Michelle N Eakin
Journal:  Crit Care       Date:  2016-10-26       Impact factor: 9.097

9.  Anxiety, Depression and Post Traumatic Stress Disorder after critical illness: a UK-wide prospective cohort study.

Authors:  Robert Hatch; Duncan Young; Vicki Barber; John Griffiths; David A Harrison; Peter Watkinson
Journal:  Crit Care       Date:  2018-11-23       Impact factor: 9.097

10.  The obesity paradox and hypoglycemia in critically ill patients.

Authors:  Drago Plečko; Nicolas Bennett; Johan Mårtensson; Rinaldo Bellomo
Journal:  Crit Care       Date:  2021-11-01       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.